ArticleJournal of cancer research and clinical oncology2012

Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.

Guangying Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.